Poly Mamoshina retweeted
Spread the word. Oxford is looking for a Senior Bioinformatician in Integrative Analysis to conduct research on covid genomic data using networks, topological data analysis, tensors, and ML. Deadline 1 October. my.corehr.com/pls/uoxrecruit…
Poly Mamoshina retweeted
What’s your biological age? A new app promises to reveal it—and help you slow the aging process fortune.com/2020/09/17/whats…
Poly Mamoshina retweeted
My friends at @HLTHEVENT, please drop by Track 3 for the Drug Discovery session. #HLTH #drugdiscovery
And that’s how you get from @HLTHEVENT registration to Track 3 for the session on #AI featuring #JNJ @melindarichter @medopad @gavinteo @biogerontology @danvahdat #HLTH2019 registration => escalator 1 => escalator 2 = you’ve arrived at track 3. 👀 you there.
Poly Mamoshina retweeted
Considering the overwhelming media coverage of this AI feat in the West and >12 Russian authors it is surprising how little coverage the article gets in Russia.
Here's a small post I put together to somehow alleviate the issue of domestic radio silence
pikabu.ru/story/ii_ot_rossiy…
Poly Mamoshina retweeted
Insilico Medicine Secures $37M in Series B Funding Led by Qiming Venture Partners finance.yahoo.com/news/insil… via @YahooFinance
Poly Mamoshina retweeted
#Deeplearning enables rapid identification of potent DDR1 kinase inhibitors go.nature.com/2kbJVvr
Poly Mamoshina retweeted
Replying to @NatureBiotech @InSilicoMeds @biogerontology @UofT @VectorInst @A_Aspuru_Guzik @WuXi_AppTec @Forbes @Dereklowe
AI identifies drug candidate in weeks. Experts are impressed by the speed of the effort, but not the difficulty #NBTintheNews via @cenmag cen.acs.org/content/cen/arti…
Poly Mamoshina retweeted
The bust of the Blockchain bubble was detrimental to many projects intended to return control and ownership of human life data to the hands of individuals but new applications have started to emerge. by @biogerontology and @geochurch in @TrendsMolecMed
cell.com/trends/molecular-me…
Poly Mamoshina retweeted
Investing in the Age of Longevity panel discussion at the #MasterInvestorShow2019 is one to remember. A big thank you to @gbpalantir, @aubreydegrey @agexthera @AgingBio @insilico who shared the latest developments in this space and discussed about the opportunities for investment
Poly Mamoshina retweeted
We have some great news: the laboratories of Jianfeng Pei at Peking University and Alex Zhavoronkov at @InSilicoMeds partner with Frontiers in Pharmacology @FrontPharmacol, on the research topic "AI for drug discovery and development"
eurekalert.org/pub_releases/…
Poly Mamoshina retweeted
Boom! First special issue on #deeplearning in #drugdiscovery by @Mol_Pharm, best molchem pharma journal. The covergirl from this journal is on the @NipsConference waiting list. Hope she gets a ticket or I will have to pass on my gold sponsor pass. pubs.acs.org/toc/mpohbp/15/1…
Poly Mamoshina retweeted
Find the Insilico logo #biodatacongress
Poly Mamoshina retweeted
How AI is changing cancer care and research? medium.com/infermedica/how-a… #insilico #TalkwalkerAlerts via @talkwalker
Poly Mamoshina retweeted
#BioDataWorld is sold out. All pharma is here. Top speakers, top delegates, top everything. It is massive!
Looking forward to @bbod 's talk. Free for Roche and Novartis. Come tomorrow for even a bigger day! #biodatacongress – at Basel, Switzerland
Poly Mamoshina retweeted
Replying to @biogerontology
@biogerontology @InSilicoMeds identifies how collaborations drive successful outcomes in #longevity science at #longevityleaders in February, London bit.ly/2PjtaMU #aging #geroscience
Poly Mamoshina retweeted
Application deadline for a postdoc with me and @shimon8282 in Bayesian Deep Learning & Reinforcement Learning has been extended by a week:
cs.ox.ac.uk/news/1582-full.h…
Ping me if you have any questions @OATML_Oxford
Poly Mamoshina retweeted
Insilico to present the latest advances at Global Precision Medicine & Biomarkers Leaders Summit eurekalert.org/e/8nmz via @InSilicoMeds @EurekAlert
Poly Mamoshina retweeted
A few weeks ago, I hosted a webinar with Alex Zhavoronkov, CEO at Insilico Medicine, on extending healthy longevity. This morning, Insilico announced a strategic round of funding led by WuXi AppTec with participation from BOLD Capital Partners: medium.com/@longevity/the-ne…























